Last reviewed · How we verify

NCT05499689

Transcutaneous Pulsed Radiofrequency in Migraine

Status unknown NA Last updated 3 February 2023
What this trial tests

NA trial testing Bupivacaine Hydrochloride in Migraine Disorders in 60 participants. Status unknown.

Timeline
22 June 2021
Primary endpoint
22 June 2023
22 August 2023

Quick facts

Lead sponsorDiskapi Teaching and Research Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment60
Start date22 June 2021
Primary completion22 June 2023
Estimated completion22 August 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Diskapi Teaching and Research Hospital

Who can join

Adults 18 to 65, any sex, with Migraine Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the investigator is to compare the efficacy of greater occipital nerve block and transcutaneous pulsed radiofrequency treatment in migraine.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A new neuromodulation method in chronic migraine; non-ınvasive pulsed radiofrequency, a single-blinded, randomised, controlled trial.
    Perdecioğlu GRG, Ateş MP, Yürük D, Can E, et al · · 2024 · cited 4× · PMID 38147268 · DOI 10.1007/s11845-023-03598-x

Verify or expand the search:

Other trials of Bupivacaine Hydrochloride

Trials testing the same drug.

Other recruiting trials for Migraine Disorders

Currently open trials in the same condition.

Other Diskapi Teaching and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05499689.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing